1. Companies
  2. Exicure
  3. Team

  4. Team

Exicure

Exicure

Exicure is developing a new class of immunomodulatory and gene silencing drugs against validated targets. Learn more
Launch date
Employees
2-10 people
Market cap
€2.4m
Enterprise valuation
€9m (Public information from Sep 2024)
Chicago Illinois (HQ)
http://exicuretx.com
https://twitter.com/exicurehttp://www.facebook.com/pages/AuraSense-Therapeutics/308079542559695https://www.linkedin.com/company/exicure
View job openings
Authorizing premium user...